🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Preparation and Molecular Composition of an Inclusion Complex of Dilsulfiram and Hydroxypropyl-β-Cyclodextrin


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

An original method is proposed for preparing an inclusion complex based on disulfiram with hydroxypropyl-β-cyclodextrin for the treatment of cataract. Preparation of soluble product required a molar ratio of hydroxypropyl-β-cyclodextrin to disulfiram of at least 2:1, while the molar ratio of components in the inclusion complex was 1:1. Gel permeation chromatography was used to measure the mean hydrodynamic diameter of hydroxypropyl-β-cyclodextrin and inclusion complex molecules, and their molecular weights were calculated – which in both cases were 1.0 kDa. A scheme for the equilibrium of the inclusion complex is proposed.

About the authors

V. S. Tyukova

M. V. Lomonosov Moscow Technology University; Institute of Pharmaceutical Technology

Author for correspondence.
Email: sk-vika@yandex.ru
Russian Federation, 78 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Highway, Moscow, 121353

S. A. Kedik

M. V. Lomonosov Moscow Technology University; Institute of Pharmaceutical Technology

Email: zhavoronokelena@mail.ru
Russian Federation, 78 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Highway, Moscow, 121353

A. V. Panov

M. V. Lomonosov Moscow Technology University; Institute of Pharmaceutical Technology

Email: zhavoronokelena@mail.ru
Russian Federation, 78 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Highway, Moscow, 121353

E. S. Zhavoronok

M. V. Lomonosov Moscow Technology University; Institute of Pharmaceutical Technology

Author for correspondence.
Email: zhavoronokelena@mail.ru
Russian Federation, 78 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Highway, Moscow, 121353

M. S. Zolotareva

M. V. Lomonosov Moscow Technology University

Email: zhavoronokelena@mail.ru
Russian Federation, 78 Vernadskii Prospekt, Moscow, 119571

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Springer Science+Business Media New York